Gain Therapeutics, Inc.GANXNASDAQ
LOADING
|||
Operating Income Contraction
Below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-20.35M
↓ 76% below average
Average (6y)
$-11.54M
Historical baseline
Range
High:$-1.03M
Low:$-22.25M
CAGR
+64.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-20.35M | +8.5% |
| 2023 | $-22.25M | -25.2% |
| 2022 | $-17.78M | -28.6% |
| 2021 | $-13.83M | -297.4% |
| 2020 | $-3.48M | -65.7% |
| 2019 | $-2.10M | -104.2% |
| 2018 | $-1.03M | - |